Posted on: 23 May, 2023
A new study by researchers at the Kolling Institute estimates more than 800 million people will be living with low back pain by 2050, a 36 percent increase from 2020.
The prediction follows an analysis of 30 years of global health data from over 200 countries.
Modelling shows the number of back pain cases globally will rise to 843 million people by 2050, while in Australia, it’s expected there will.....
Read more
Category: Musculoskeletal Research
Posted on: 14 April, 2023
In a sign of the international impact of our research at the Kolling Institute, a prestigious award has been presented to Professor Chris Little during the World Congress on Osteoarthritis in Denver, Colorado.
More than 700 researchers and clinicians attended the event where Professor Little was presented with the 2023 Basic Science Research Award by the Osteoarthritis Research Society Internationa.....
Read more
Category: Awards, Musculoskeletal Research, Research Excellence
Posted on: 14 February, 2023
We are pleased to announce the successful recipients of our annual Kolling Institute awards program.
Launched in 2021, the program has been expanded to acknowledge a greater number of researchers and their individual contribution to the Kolling.
The awards aim to recognise the many outstanding achievements across education, clinical practice and service, publications, research, as well as overall a.....
Read more
Category: Awards, Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research
Posted on: 20 January, 2023
With an increasing number of people suffering anterior cruciate ligament (ACL) injuries, researchers at the Kolling Institute say a broader range of tendon grafts could be successfully adopted by surgeons undertaking knee reconstructions.
The research, which is the second-largest human tendon study ever published, is prompting calls for tissue banks to review current age restrictions and the range .....
Read more
Category: Musculoskeletal Research, Research Excellence
Posted on: 12 October, 2022
Arthritis is the third most prevalent long-term health condition in Australia affecting more than 12 per cent of Australians.
There is no cure for arthritis, with treatment options largely focused on alleviating pain, including pain relief medication, arthroscopy or joint replacement.
Australia is at the forefront of clinical research and trials, which is helping the community better manage their a.....
Read more
Category: Musculoskeletal Research, Research Excellence
Posted on: 26 September, 2022
We would like to congratulate Professor Chris Little who has received a highly coveted award for his outstanding commitment to orthopaedic research.
Professor Little has been elected a Fellow of International Orthopaedic Research at a key international conference in Edinburgh Scotland. The award is only presented every three years, with around 20 people across the globe receiving the accolade.
Fell.....
Read more
Category: Musculoskeletal Research, Presentations, Research Excellence
Posted on: 22 September, 2022
A $400,000 robot which may hold the key to significant improvements in hip and knee replacements is now operational at the Kolling Institute.
Known as KOBRA or the Kolling Orthopaedic Biomechanics Robotic Arm, the new technology delivers an advanced testing facility, while greatly increasing research capabilities.
It is the largest of its kind in Australia and one of just two SimVitro robots in the.....
Read more
Category: Musculoskeletal Research, Research Excellence, World-leading technology
Posted on: 16 September, 2022
Kolling Institute researchers have helped map out exciting future developments for the rehabilitation of hip and knee replacement patients.
A team of researchers from Sydney Musculoskeletal Health – a partnership between the University of Sydney, Sydney Local Health District and Northern Sydney Local Health District - recently attended the International Society for Technology in Arthroplasty’s annu.....
Read more
Category: Musculoskeletal Research, Presentations, Research Excellence
Posted on: 29 July, 2022
Our researchers are seeking participants for a large-scale clinical trial pioneering the use of stem cells to treat and potentially cure osteoarthritis.
The disease is now one of the leading causes of disability in the world, affecting around three million people in Australia alone.
Royal North Shore Hospital rheumatologist Professor David Hunter is leading the two-year trial which is recruiting ar.....
Read more
Category: Musculoskeletal Research, New Treatment
Posted on: 01 June, 2022
The largest study in Australia into the treatment of juvenile arthritis may pave the way for a unique approach to care for those with the disabling condition and dramatically improve outcomes.
The Medical Research Future Fund will invest $2.5 million in the A3BC for Kids project which will involve researchers from the Kolling Institute and the University of Sydney in collaboration with the Australi.....
Read more
Category: Funding support, Musculoskeletal Research